{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:43:11Z","timestamp":1793191391760,"version":"4.5.0"},"reference-count":194,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting about 0. 5\u20131% of the adult population and manifesting as persistent synovitis, systemic inflammation and production of autoantibodies. Patients affected by RA not only experience chronic disease progression, but are also burdened by a 1.5-fold increased cardiovascular (CV) risk, which is comparable to the risk experienced by patients with type 2 diabetes mellitus. RA patients also have a higher incidence and prevalence of coronary artery disease (CAD). Although RA patients frequently present traditional CV risk factors such as insulin resistance and active smoking, previous studies have clarified the pivotal role of chronic inflammation\u2013driven by proinflammatory cytokines such as interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha)\u2013in accelerating the process of atherosclerosis and impairing the coagulation system. Over the last years, a number of studies have shown that disease-modifying anti-rheumatic drugs (DMARDs) reducing the inflammatory state in general improve the CV risk, however some drugs may carry some apparent negative effects. Thus, RA is a model of disease in which targeting inflammation may counteract the progression of atherosclerosis and reduce CV risk. Clinical and experimental evidence indicates that the management of RA patients should be tailored based on the positive and negative effects of DMARDs on CV risk together with the individual traditional CV risk profile. The identification of genetic, biochemical and clinical biomarkers, predictive of evolution and response to treatment, will be the next challenge for a precision approach to reduce the burden of the disease.<\/jats:p>","DOI":"10.3389\/fcvm.2022.1012661","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T05:07:25Z","timestamp":1666588045000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis"],"prefix":"10.3389","volume":"9","author":[{"given":"Andrea","family":"Giachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gualtierotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102735","DOI":"10.1016\/j.autrev.2020.102735","article-title":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis","volume":"20","author":"Conforti","year":"2021","journal-title":"Autoimmun Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.3390\/cells10112857","article-title":"Management of rheumatoid arthritis: an overview","volume":"10","author":"Radu","year":"2021","journal-title":"Cells"},{"key":"B3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.berh.2018.10.005","article-title":"Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis","volume":"32","author":"van der Woude","year":"2018","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B4","first-page":"1620","article-title":"Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol","volume":"17","author":"Goemaere","year":"1990"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00296-017-3726-1","article-title":"Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014","volume":"37","author":"Hunter","year":"2017","journal-title":"Rheumatol Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/annrheumdis-2019-216694","article-title":"Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985-2014","volume":"79","author":"Myasoedova","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"k1036","DOI":"10.1136\/bmj.k1036","article-title":"Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications","volume":"361","author":"England","year":"2018","journal-title":"BMJ."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S2665-9913(20)30221-6","article-title":"Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout","volume":"3","author":"Hansildaar","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41927-018-0014-y","article-title":"Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment","volume":"2","author":"Jagpal","year":"2018","journal-title":"BMC Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/rheumatology\/keaa374","article-title":"Cardiovascular risk and mortality in rheumatoid arthritis compared with diabetes mellitus and the general population","volume":"60","author":"Logstrup","year":"2021","journal-title":"Rheumatology (Oxford)."},{"key":"B11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B12","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1056\/NEJM199006073222302","article-title":"Activation of coagulation after administration of tumor necrosis factor to normal subjects","volume":"322","author":"van der Poll","year":"1990","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semarthrit.2008.02.001","article-title":"Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis","volume":"38","author":"Gonzalez-Gay","year":"2008","journal-title":"Semin Arthritis Rheum."},{"key":"B15","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/eurheartj\/ehu403","article-title":"Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions","volume":"36","author":"Mason","year":"2015","journal-title":"Eur Heart J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"R158","DOI":"10.1186\/ar3116","article-title":"Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness","volume":"12","author":"Sodergren","year":"2010","journal-title":"Arthritis Res Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/rheumatology\/kem202","article-title":"Systemic inflammation as a risk factor for atherothrombosis","volume":"47","author":"van Leuven","year":"2008","journal-title":"Rheumatology (Oxford)."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s10067-017-3796-1","article-title":"Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study","volume":"36","author":"Jean","year":"2017","journal-title":"Clin Rheumatol."},{"key":"B19","first-page":"445","article-title":"Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden","volume":"24","author":"Wallberg-Jonsson","year":"1997","journal-title":"J Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/art.21628","article-title":"Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations","volume":"54","author":"Liang","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/annrheumdis-2016-209562","article-title":"Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap","volume":"76","author":"Lacaille","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.berh.2007.05.003","article-title":"Mortality in established rheumatoid arthritis","volume":"21","author":"Naz","year":"2007","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avina-Zubieta","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B24","first-page":"S35","article-title":"Mortality in rheumatoid arthritis: 2008 update","volume":"26","author":"Sokka","year":"2008","journal-title":"Clin Exp Rheumatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3899\/jrheum.161154","article-title":"Decreased cardiovascular mortality in patients with incident rheumatoid arthritis (ra) in recent years: dawn of a new era in cardiovascular disease in RA?","volume":"44","author":"Myasoedova","year":"2017","journal-title":"J Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00296-016-3638-5","article-title":"Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study","volume":"37","author":"van den Hoek","year":"2017","journal-title":"Rheumatol Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2474-15-142","article-title":"Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature","volume":"15","author":"Meek","year":"2014","journal-title":"BMC Musculoskelet Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3899\/jrheum.200842","article-title":"Improved incidence of cardiovascular disease in patients with incident rheumatoid arthritis in the 2000s: a population-based cohort study","volume":"48","author":"Myasoedova","year":"2021","journal-title":"J Rheumatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.semarthrit.2021.03.003","article-title":"Has the excess risk of acute myocardial infarction in rheumatoid arthritis relative to the general population declined? A population study of trends over time","volume":"51","author":"Yazdani","year":"2021","journal-title":"Semin Arthritis Rheum."},{"key":"B31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/annrheumdis-2017-212131","article-title":"Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?","volume":"77","author":"Holmqvist","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000514889","article-title":"Increased incidence of stroke and transient ischemic attack in patients with rheumatoid arthritis and ankylosing spondylitis in Germany","volume":"55","author":"Trommer","year":"2021","journal-title":"Neuroepidemiology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0251851","DOI":"10.1371\/journal.pone.0251851","article-title":"Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: a nationwide longitudinal cohort study","volume":"16","author":"Lee","year":"2021","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/art.21560","article-title":"Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis","volume":"54","author":"Nicola","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12947","article-title":"Incidence of congestive heart failure in rheumatoid arthritis: a review of literature and meta-regression analysis","author":"Khalid","year":"2020","journal-title":"ESC Heart Fail."},{"key":"B36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1160\/TH15-07-0600","article-title":"Risk of peripheral arterial occlusive disease in patients with rheumatoid arthritis. A nationwide population-based cohort study","volume":"115","author":"Chuang YW Yu","year":"2016","journal-title":"Thromb Haemost."},{"key":"B37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2010.05.007","article-title":"Subclinical peripheral arterial disease in rheumatoid arthritis","volume":"212","author":"Stamatelopoulos","year":"2010","journal-title":"Atherosclerosis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/annrheumdis-2020-218419","article-title":"Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden","volume":"80","author":"Molander","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10067-014-2492-7","article-title":"Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"33","author":"Ungprasert","year":"2014","journal-title":"Clin Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.autrev.2003.10.006","article-title":"Endothelial dysfunction in rheumatoid arthritis: influence of HLA-DRB1 alleles","volume":"3","author":"Gonzalez-Gay","year":"2004","journal-title":"Autoimmun Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.01.024","article-title":"Proinflammatory HLA-DRB1*01-haplotype predisposes to ST-elevation myocardial infarction","volume":"221","author":"Paakkanen","year":"2012","journal-title":"Atherosclerosis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2008.096487","article-title":"Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies","volume":"69","author":"Sugiyama","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/ar2751","article-title":"Rheumatoid arthritis and smoking: putting the pieces together","volume":"11","author":"Baka","year":"2009","journal-title":"Arthritis Res Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ajhg.2011.03.003","article-title":"Tobacco-smoking-related differential DNA methylation: 27K discovery and replication","volume":"88","author":"Breitling","year":"2011","journal-title":"Am J Hum Genet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/ard.2005.041079","article-title":"Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles","volume":"65","author":"Linn-Rasker","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/archinte.165.14.1624","article-title":"Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation","volume":"165","author":"Escalante","year":"2005","journal-title":"Arch Intern Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1172\/JCI117244","article-title":"Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation","volume":"93","author":"Roubenoff","year":"1994","journal-title":"J Clin Invest."},{"key":"B48","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/annrheumdis-2013-204987","article-title":"Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration","volume":"75","author":"Navarro-Millan","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1002\/art.20720","article-title":"Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis","volume":"50","author":"Liao","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0164564","DOI":"10.1371\/journal.pone.0164564","article-title":"Patients with rheumatoid arthritis show altered lipoprotein profiles with dysfunctional high-density lipoproteins that can exacerbate inflammatory and atherogenic process","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS ONE."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1002\/art.24802","article-title":"Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis","volume":"60","author":"Charles-Schoeman","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B53","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/annrheumdis-2012-202914","article-title":"Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus","volume":"73","author":"Ronda","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1002\/art.34363","article-title":"Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/annrheumdis-2011-200493","article-title":"Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis","volume":"71","author":"Charles-Schoeman","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/art.23255","article-title":"Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study","volume":"59","author":"Sokka","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B57","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1136\/annrheumdis-2013-204531","article-title":"The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients","volume":"74","author":"Arts","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e0176291","DOI":"10.1371\/journal.pone.0176291","article-title":"Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis","volume":"12","author":"Boo","year":"2017","journal-title":"PLoS ONE."},{"key":"B59","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/acr.20106","article-title":"Motivation as a determinant of physical activity in patients with rheumatoid arthritis","volume":"62","author":"Hurkmans","year":"2010","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"B60","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2006.052506","article-title":"Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis","volume":"66","author":"Turesson","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1136\/ard.2009.122226","article-title":"Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity","volume":"69","author":"Solomon","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/art.25009","article-title":"Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis","volume":"61","author":"Rho","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1002\/art.30542","article-title":"Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis","volume":"63","author":"Giles","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/art.39267","article-title":"Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study","volume":"67","author":"Mantel","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/art.39098","article-title":"Disease activity in rheumatoid arthritis and the risk of cardiovascular events","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/art.22482","article-title":"HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis","volume":"57","author":"Gonzalez-Gay","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1136\/annrheumdis-2013-204715","article-title":"The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis","volume":"73","author":"Zhang","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1136\/annrheumdis-2013-203314","article-title":"Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography","volume":"73","author":"Fine","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1136\/ard.2009.124362","article-title":"Increased prevalence of diastolic dysfunction in rheumatoid arthritis","volume":"69","author":"Liang","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/annrheumdis-2014-eular.1865","article-title":"Left ventricular function in treatment-naive early rheumatoid arthritis","volume":"4","author":"Logstrup","year":"2014","journal-title":"Am J Cardiovasc Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/rheumatology\/keu368","article-title":"Disease activity and left ventricular structure in patients with rheumatoid arthritis","volume":"54","author":"Midtbo","year":"2015","journal-title":"Rheumatology (Oxford)."},{"key":"B74","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/annrheumdis-2016-209223","article-title":"Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis","volume":"76","author":"Midtbo","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2013.02.009","article-title":"Antibodies to citrullinated peptides and risk of coronary heart disease","volume":"228","author":"Cambridge","year":"2013","journal-title":"Atherosclerosis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/art.24390","article-title":"Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis","volume":"61","author":"Lopez-Longo","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1002\/art.39198","article-title":"Rheumatoid arthritis, anti-cyclic citrullinated peptide positivity, and cardiovascular disease risk in the women's health initiative","volume":"67","author":"Mackey","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/art.27349","article-title":"Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging","volume":"62","author":"Giles","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/rheumatology\/ker121","article-title":"Are the anti-cyclic citrullinated peptide antibodies independent predictors of myocardial involvement in patients with active rheumatoid arthritis?","volume":"50","author":"Marasovic-Krstulovic","year":"2011","journal-title":"Rheumatology (Oxford)."},{"key":"B80","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/rheumatology\/kes353","article-title":"Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study","volume":"52","author":"Avina-Zubieta","year":"2013","journal-title":"Rheumatology (Oxford)."},{"key":"B82","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/art.38210","article-title":"Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis","volume":"66","author":"Battafarano","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1136\/annrheumdis-2015-207870","article-title":"Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis","volume":"75","author":"Zhang","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3899\/jrheum.121507","article-title":"Cholesteryl ester transfer protein in patients with rheumatoid arthritis","volume":"40","author":"Ferraz-Amaro","year":"2013","journal-title":"J Rheumatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1136\/ard.45.9.790-b","article-title":"Corticosteroids in rheumatoid arthritis","volume":"45","author":"Nashel","year":"1986","journal-title":"Ann Rheum Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.semarthrit.2005.03.004","article-title":"Rheumatoid arthritis: a disease associated with accelerated atherogenesis","volume":"35","author":"Gonzalez-Gay","year":"2005","journal-title":"Semin Arthritis Rheum."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation."},{"key":"B88","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrrheum.2015.40","article-title":"Atherosclerosis in rheumatoid arthritis: is it all about inflammation?","volume":"11","author":"Skeoch","year":"2015","journal-title":"Nat Rev Rheumatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/rheumatology\/ker232","article-title":"Cardiovascular risk and rheumatoid arthritis\u2013the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation","volume":"50","author":"Kozera","year":"2011","journal-title":"Rheumatology (Oxford)."},{"key":"B90","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.3390\/ijms150711324","article-title":"Endothelial dysfunction in chronic inflammatory diseases","volume":"15","author":"Steyers","year":"2014","journal-title":"Int J Mol Sci."},{"key":"B91","first-page":"183","article-title":"Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome","volume":"1","author":"Hadi","year":"2005","journal-title":"Vasc Health Risk Manag"},{"key":"B92","first-page":"III12","article-title":"Intact and altered endothelium in regulation of vasomotion","volume":"86","author":"Lerman","year":"1992","journal-title":"Circulation"},{"key":"B93","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13075-018-1768-8","article-title":"TNFalpha expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis","volume":"20","author":"Barbati","year":"2018","journal-title":"Arthritis Res Ther."},{"key":"B94","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.ejim.2015.10.016","article-title":"Clinical assessment of endothelial function in patients with rheumatoid arthritis: A meta-analysis of literature studies","volume":"26","author":"Di Minno","year":"2015","journal-title":"Eur J Intern Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.arcmed.2019.10.010","article-title":"Assessment of aortic stiffness in patients with rheumatoid arthritis using pulse wave velocity: an update meta-analysis","volume":"50","author":"Wang","year":"2019","journal-title":"Arch Med Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1253\/circj.cj-09-0274","article-title":"Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis","volume":"73","author":"Ku","year":"2009","journal-title":"Circ J."},{"key":"B97","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.cyto.2012.02.010","article-title":"Atherogenic effects of TNF-alpha and IL-6 via up-regulation of scavenger receptors","volume":"58","author":"Hashizume","year":"2012","journal-title":"Cytokine."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/1535370213503262","article-title":"Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages","volume":"238","author":"Voloshyna","year":"2013","journal-title":"Exp Biol Med (Maywood)."},{"key":"B99","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/08916934.2015.1118761","article-title":"Accelerated transformation of macrophage-derived foam cells in the presence of collagen-induced arthritis mice serum is associated with dyslipidemia","volume":"49","author":"Wen","year":"2016","journal-title":"Autoimmunity."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1161\/01.cir.100.21.2124","article-title":"tale of two diseases: atherosclerosis and rheumatoid arthritis","volume":"100","author":"Pasceri","year":"1999","journal-title":"Circulation."},{"key":"B101","doi-asserted-by":"publisher","first-page":"S419","DOI":"10.1016\/s0002-8703(99)70266-8","article-title":"Atherosclerosis is an inflammatory disease","volume":"138","author":"Ross","year":"1999","journal-title":"Am Heart J."},{"key":"B102","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/rheumatology\/36.2.164","article-title":"distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis","volume":"36","author":"Littler","year":"1997","journal-title":"Br J Rheumatol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/030097498442415","article-title":"Soluble cell adhesion molecules\u2013P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis","volume":"27","author":"Veale","year":"1998","journal-title":"Scand J Rheumatol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/ar2286","article-title":"Skewed distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis","volume":"9","author":"Fasth","year":"2007","journal-title":"Arthritis Res Ther."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1002\/art.20678","article-title":"Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma","volume":"50","author":"Radstake","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1161\/01.CIR.0000127121.16815.F1","article-title":"B7-1\/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice","volume":"109","author":"Buono","year":"2004","journal-title":"Circulation."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1002\/art.22690","article-title":"Inflammatory rheumatic disease and smoking are predictors of aortic inflammation: a controlled study of biopsy specimens obtained at coronary artery surgery","volume":"56","author":"Hollan","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B108","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/1744666X.2021.1899809","article-title":"Biologics and atherosclerotic cardiovascular risk in rheumatoid arthritis: a review of evidence and mechanistic insights","volume":"17","author":"Karpouzas","year":"2021","journal-title":"Expert Rev Clin Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/annrheumdis-2015-208442","article-title":"Anti-TNFalpha agents curb platelet activation in patients with rheumatoid arthritis","volume":"75","author":"Manfredi","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","article-title":"Concept of vulnerable\/unstable plaque","volume":"30","author":"Finn","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby","year":"2008","journal-title":"Am J Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/bf02231572","article-title":"Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis","volume":"12","author":"W\u00e5llberg-Jonsson","year":"1993","journal-title":"Clin Rheumatol."},{"key":"B113","first-page":"139","article-title":"The relationship between inflammation and the coagulation system","volume":"136","author":"Choi","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"B114","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1161\/01.Cir.0000131660.51520.9a","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation."},{"key":"B115","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.trsl.2010.10.003","article-title":"Cardiovascular events and survival in rheumatoid arthritis: effects of anti-tumor necrosis factor-alpha treatment","volume":"157","author":"Cugno","year":"2011","journal-title":"Transl Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jaut.2008.07.002","article-title":"Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade","volume":"31","author":"Ingegnoli","year":"2008","journal-title":"J Autoimmun."},{"key":"B117","first-page":"254","article-title":"Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis","volume":"28","author":"Ingegnoli","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.1181928","article-title":"Platelets amplify inflammation in arthritis via collagen-dependent microparticle production","volume":"327","author":"Boilard","year":"2010","journal-title":"Science."},{"key":"B119","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1160\/TH17-09-0630","article-title":"The pathophysiological role of neutrophil extracellular traps in inflammatory diseases","volume":"118","author":"Bonaventura","year":"2018","journal-title":"Thromb Haemost."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science."},{"key":"B121","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3389\/fimmu.2016.00485","article-title":"NETosis as Source of autoantigens in rheumatoid arthritis","volume":"7","author":"Corsiero","year":"2016","journal-title":"Front Immunol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci Transl Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"R122","DOI":"10.1186\/ar4579","article-title":"Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility","volume":"16","author":"Sur Chowdhury","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"B124","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","article-title":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood."},{"key":"B126","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.micinf.2014.10.001","article-title":"Inflammation-induced DNA damage and damage-induced inflammation: a vicious cycle","volume":"16","author":"Palmai-Pallag","year":"2014","journal-title":"Microbes Infect."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/eurheartj\/ehv007","article-title":"Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction","volume":"36","author":"Stakos","year":"2015","journal-title":"Eur Heart J."},{"key":"B128","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12931-016-0472-y","article-title":"Pulmonary endothelial activation caused by extracellular histones contributes to neutrophil activation in acute respiratory distress syndrome","volume":"17","author":"Zhang","year":"2016","journal-title":"Respir Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1161\/circresaha.116.304944","article-title":"Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size","volume":"116","author":"Mangold","year":"2015","journal-title":"Circ Res."},{"key":"B130","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2013-204317","article-title":"Proposal for a new nomenclature of disease-modifying antirheumatic drugs","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3899\/jrheum.130365","article-title":"Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study","volume":"40","author":"Ajeganova","year":"2013","journal-title":"J Rheumatol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/art.22643","article-title":"The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice","volume":"56","author":"Montesinos","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B133","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/annrheumdis-2014-206305","article-title":"Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation","volume":"75","author":"Thornton","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B134","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.redox.2017.07.018","article-title":"Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging","volume":"13","author":"Zimmerman","year":"2017","journal-title":"Redox Biol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/biof.17","article-title":"Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms","volume":"35","author":"Zhou","year":"2009","journal-title":"Biofactors."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1136\/annrheumdis-2015-208995","article-title":"Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis","volume":"75","author":"Ljung","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B137","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/annrheumdis-2011-201148","article-title":"Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis","volume":"71","author":"Da\u00efen","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B138","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/annrheumdis-2012-201489","article-title":"Etanercept normalises left ventricular mass in patients with rheumatoid arthritis","volume":"72","author":"Daien","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B139","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/HYPERTENSIONAHA.109.143982","article-title":"Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study","volume":"55","author":"Angel","year":"2010","journal-title":"Hypertension."},{"key":"B140","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ejphar.2015.08.054","article-title":"Differential effects of anti-TNF-alpha and anti-IL-12\/23 agents on human leukocyte-endothelial cell interactions","volume":"765","author":"Rios-Navarro","year":"2015","journal-title":"Eur J Pharmacol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.trsl.2016.12.003","article-title":"Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation","volume":"183","author":"Ruiz-Lim\u00f3n","year":"2017","journal-title":"Transl Res."},{"key":"B142","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/art.41095","article-title":"Cardiovascular safety of tocilizumab versus etanercept in rheumatoid arthritis: a randomized controlled trial","volume":"72","author":"Giles","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1194\/jlr.P052209","article-title":"IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans","volume":"56","author":"M\u00fcller","year":"2015","journal-title":"J Lipid Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/rheumatology\/kez265","article-title":"Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up","volume":"59","author":"Fleischmann","year":"2020","journal-title":"Rheumatology (Oxford)."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00392-019-01443-9","article-title":"Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function","volume":"108","author":"Ikonomidis","year":"2019","journal-title":"Clin Res Cardiol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med."},{"key":"B147","doi-asserted-by":"publisher","first-page":"e001267","DOI":"10.1161\/jaha.114.001267","article-title":"Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis","volume":"3","author":"Hsue","year":"2014","journal-title":"J Am Heart Assoc."},{"key":"B148","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s10067-009-1095-1","article-title":"Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis","volume":"28","author":"Kerekes","year":"2009","journal-title":"Clin Rheumatol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13075-015-0671-9","article-title":"Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE)","volume":"17","author":"Smolen","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B150","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/btt.S52003","article-title":"Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis","volume":"7","author":"Mathieu","year":"2013","journal-title":"Biologics."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e0130709","DOI":"10.1371\/journal.pone.0130709","article-title":"The impact of newer biological disease modifying anti-rheumatic drugs on cardiovascular risk factors: a 12-month longitudinal study in rheumatoid arthritis patients treated with rituximab, abatacept and tociliziumab","volume":"10","author":"Provan","year":"2015","journal-title":"PLoS ONE."},{"key":"B152","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1097\/md.0000000000000888","article-title":"Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study","volume":"94","author":"Ursini","year":"2015","journal-title":"Medicine (Baltimore)."},{"key":"B153","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/art.38974","article-title":"Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib","volume":"67","author":"Charles-Schoeman","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.semarthrit.2016.03.004","article-title":"Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist","volume":"46","author":"Charles-Schoeman","year":"2016","journal-title":"Semin Arthritis Rheum."},{"key":"B155","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med."},{"key":"B156","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/annrheumdis-2021-221915","article-title":"Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study","volume":"81","author":"Khosrow-Khavar","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3899\/jrheum.111334","article-title":"Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis \u2013 an inception cohort study","volume":"39","author":"Ajeganova","year":"2012","journal-title":"J Rheumatol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3899\/jrheum.121012","article-title":"Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis","volume":"40","author":"Davis","year":"2013","journal-title":"J Rheumatol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"e24579","DOI":"10.1097\/MD.0000000000024579","article-title":"Methotrexate can prevent cardiovascular events in patients with rheumatoid arthritis: an updated meta-analysis","volume":"100","author":"Sun","year":"2021","journal-title":"Medicine (Baltimore)."},{"key":"B160","doi-asserted-by":"publisher","first-page":"R134","DOI":"10.1186\/ar4314","article-title":"Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis","volume":"15","author":"Chung","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B161","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semarthrit.2012.12.027","article-title":"Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study","volume":"43","author":"Guin","year":"2013","journal-title":"Semin Arthritis Rheum."},{"key":"B162","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4062\/biomolther.2014.125","article-title":"Effect of methotrexate on collagen-induced arthritis assessed by micro-computed tomography and histopathological examination in female rats","volume":"23","author":"Kim","year":"2015","journal-title":"Biomol Ther (Seoul)."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/art.10269","article-title":"Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis","volume":"46","author":"Kumeda","year":"2002","journal-title":"Arthritis Rheum."},{"key":"B164","first-page":"58","article-title":"Early phase clinical and biological markers associated with subclinical atherosclerosis measured at 7 years of evolution in an early inflammatory arthritis cohort","volume":"34","author":"Vandhuick","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/03009740410010308","article-title":"Which factors are related to the presence of atherosclerosis in rheumatoid arthritis?","volume":"33","author":"Wallberg-Jonsson","year":"2004","journal-title":"Scand J Rheumatol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/rheumatology\/41.6.658","article-title":"Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis","volume":"41","author":"van Ede","year":"2002","journal-title":"Rheumatology (Oxford)."},{"key":"B167","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti\u2013tumor necrosis factor \u03b1 therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis & Rheumatism"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/rheumatology\/kem089","article-title":"Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis","volume":"46","author":"Del Porto","year":"2007","journal-title":"Rheumatology (Oxford)."},{"key":"B169","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00296-019-04503-5","article-title":"A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis","volume":"40","author":"Davida","year":"2020","journal-title":"Rheumatol Int."},{"key":"B170","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/bf00832010","article-title":"Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody","volume":"20","author":"Yoshizaki","year":"1998","journal-title":"Springer Semin Immunopathol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1007\/s12325-019-01118-x","article-title":"Tocilizumab effects on coagulation factor XIII in patients with rheumatoid arthritis","volume":"36","author":"Gualtierotti","year":"2019","journal-title":"Adv Ther."},{"key":"B172","first-page":"451","article-title":"Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade","volume":"34","author":"Gualtierotti","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.semarthrit.2014.07.006","article-title":"Tocilizumab in rheumatoid arthritis: a case study of safety evaluations of a large postmarketing data set from multiple data sources","volume":"44","author":"Curtis","year":"2015","journal-title":"Semin Arthritis Rheum."},{"key":"B174","doi-asserted-by":"publisher","first-page":"e14328","DOI":"10.1371\/journal.pone.0014328","article-title":"Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases","volume":"5","author":"Schultz","year":"2010","journal-title":"PLoS ONE."},{"key":"B175","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/jcm9072157","article-title":"Anti-atherogenic modification of serum lipoprotein function in patients with rheumatoid arthritis after tocilizumab treatment, a pilot study","author":"Greco","year":"2020","journal-title":"J Clin Med"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1136\/annrheumdis-2013-204405","article-title":"Sarilumab, a fully human monoclonal antibody against IL-6R\u03b1 in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial","volume":"73","author":"Huizinga","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B177","doi-asserted-by":"publisher","first-page":"e1002901","DOI":"10.1371\/journal.pmed.1002901","article-title":"Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial","volume":"16","author":"Ruscitti","year":"2019","journal-title":"PLoS Med."},{"key":"B178","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1136\/annrheumdis-2011-201228","article-title":"protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab","volume":"72","author":"Raterman","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B179","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13075-015-0776-1","article-title":"Comparative effectiveness and safety of rituximab versus subsequent anti-tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti-tumor necrosis factor therapies in the United States Corrona registry","volume":"17","author":"Harrold","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B180","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/jaha.117.007393","article-title":"Comparative cardiovascular risk of abatacept and tumor necrosis factor inhibitors in patients with rheumatoid arthritis with and without diabetes mellitus: a multidatabase cohort study","author":"Kang","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.ijcard.2012.12.085","article-title":"T-cell co-stimulation by CD28-CD80\/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development","volume":"168","author":"Ewing","year":"2013","journal-title":"Int J Cardiol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/cvr\/cvs330","article-title":"CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE\u2013\/\u2013 mice","volume":"97","author":"Ma","year":"2013","journal-title":"Cardiovasc Res."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.mayocp.2020.01.039","article-title":"Efficacy and safety of tofacitinib, baricitinib, and upadacitinib for rheumatoid arthritis: a systematic review and meta-analysis","volume":"95","author":"Wang","year":"2020","journal-title":"Mayo Clin Proc."},{"key":"B184","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/jama.2019.9055","article-title":"Effect of filgotinib vs placebo on clinical response in patients with moderate to severe rheumatoid arthritis refractory to disease-modifying antirheumatic drug therapy: the FINCH 2 randomized clinical trial","volume":"322","author":"Genovese","year":"2019","journal-title":"Jama."},{"key":"B185","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/acr2.11232","article-title":"Postapproval comparative safety study of tofacitinib and biological disease-modifying antirheumatic drugs: 5-year results from a United States-based rheumatoid arthritis registry","volume":"3","author":"Kremer","year":"2021","journal-title":"ACR Open Rheumatol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/09537104.2021.1934665","article-title":"Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function","volume":"33","author":"Parra-Izquierdo","year":"2022","journal-title":"Platelets."},{"key":"B187","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41584-021-00593-3","article-title":"Cardiovascular effects of approved drugs for rheumatoid arthritis","volume":"17","author":"Atzeni","year":"2021","journal-title":"Nat Rev Rheumatol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/s0195-668x(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J."},{"key":"B189","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","article-title":"Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2","volume":"336","author":"Hippisley-Cox","year":"2008","journal-title":"BMJ."},{"key":"B190","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B191","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J."},{"key":"B192","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41927-020-00139-2","article-title":"Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country","volume":"4","author":"Solomon","year":"2020","journal-title":"BMC Rheumatol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"8876363","DOI":"10.1155\/2021\/8876363","article-title":"Cardiovascular risk factor profiles and disease in black compared to other africans with chronic kidney disease","volume":"2021","author":"Hsu","year":"2021","journal-title":"Int J Nephrol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4172\/2155-9929.1000350","article-title":"Cancer immunotherapy and personalized medicine: emerging technologies and biomarker-based approaches","author":"Maciejko","year":"2017","journal-title":"J Mol Biomark Diagn"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1012661\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T05:07:40Z","timestamp":1666588060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1012661\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":194,"alternative-id":["10.3389\/fcvm.2022.1012661"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1012661","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"article-number":"1012661"}}